XW-001

N/A

Report date: 2025/03/04 10:12:38

Base Information

Drug NameXW-001
Drug Alias NameXW001CPX102CPX-102
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon lambda receptor stimulants
TargetsInterferon lambda receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultRespiratory Syncytial Virus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArgentinaPeruMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Sciwind Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSino Biopharmaceutical LtdHangzhou Sciwind Biotechnology Co Ltd
Inactive CompaniesSciwind Biosciences APAC Co Pty Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Syncytial Virus InfectionsInfluenza, Human
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A